Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2023 earnings results today.
Total revenues inched up 1% to $11.5 billion versus the same period a year ago.
Net earnings attributable to BMS were $1.76 billion, or $0.87 per share, compared to $2 billion, or $0.95 per share, last year. Adjusted EPS decreased 7% to $1.70.
For full-year 2024, the company expects revenues to increase by low single-digits and adjusted EPS to range between $7.10-7.40.
Firm: Charles River Laboratories (CRL)Enterprise: Charles River Laboratories is an early-stage contract analysis firm. The corporate engages in laboratory animal...
After a combined begin to the yr, the US IPO market noticed a rise in exercise in latest months, led...
Final week, I posted an image from 2014, quickly after I returned to the U.S. after spending six months in...
Lyft, Inc. (NASDAQ: LYFT) reported a revenue for the primary quarter of 2025, in comparison with a loss final yr,...
In search of Alpha's Disclaimer: The earnings name insights are compilations of earnings name transcripts and different content material out...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
